Chari, A., Rodríguez Otero, P., McCarthy, H., Suzuki, K., Hungria, V., Sureda, A., . . . Touzeau, C. (2020). Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): An open‐label Phase II study.
Citação norma ChicagoChari, Ajai, et al. Subcutaneous Daratumumab Plus Standard Treatment Regimens in Patients With Multiple Myeloma Across Lines of Therapy (PLEIADES): An Open‐label Phase II Study. 2020.
Citação norma MLAChari, Ajai, et al. Subcutaneous Daratumumab Plus Standard Treatment Regimens in Patients With Multiple Myeloma Across Lines of Therapy (PLEIADES): An Open‐label Phase II Study. 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.